India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with weight-loss treatment giant, Eli Lilly.

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

The prospect of a President Kamala Harris facing down a Republican-controlled Senate is coming into focus as she rises in the 2024 contest, even as GOP hopes of capturing the Senate grow because ...

StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

The co-founder of biotech giant Regeneron Pharmaceuticals (REGN) recently raised concerns about the potential side effects of ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...